Aggressive Treatment De-Escalation Feasible in HPV-Positive Oropharyngeal Cancer?
This video highlights 2-year results of a phase II study evaluating aggressive adjuvant chemoradiation dose de-escalation in HPV-positive oropharynx squamous cell carcinoma.